Likewise, APOBEC3B and APOBEC2 upregulation has been linked to systemic inflammation [13], suggesting that a pro-inflammatory microenvironment in MM cells could drive APOBEC2 and APOBEC3B expression. This evidence concerns the gene APOBEC3B and Miyoshi myopathy.